Global Progenitor Cell-Based Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Sep 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Progenitor Cell-Based Market By Type (Allogeneic Stem Cell, Autologous Stem Cell), Therapeutic Application (Musculoskeletal Disorders, Wound and Injuries, Neurology, Cardiovascular Diseases (CVD), Gastrointestinal Diseases, Surgeries, Others), Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Embryo/Cord Blood Stem Cells, Others), End User (Laboratory, Hospitals, Research Institute),  Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Progenitor Cell-Based Market

Global progenitor cell-based market is estimated to register a substantial CAGR in the forecast period of 2019 to 2026. The imminent market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026. The growth of the market can be attributed to the rising geriatric population.

Market Definition: Global Progenitor Cell-Based Market

Progenitor cell are the kind of stem cell which are located in bone marrow and also called as hematopoietic. These cells give rise to the different cell lines. The progenitor cells can divide and stem cells can replicate indefinitely. Progenitor cells are used in various neurological disorders such as Parkinson disease and Huntington disease.

Prevalence of Parkinson’s disease (PD) increases with increasing age but an estimated four percent of people with Parkinson’s disease are diagnosed before age 50, more than 10 million people worldwide are living with Parkinson’s disease, and other neurological diseases.

Market Drivers

  • Rising of advanced genome-cell based techniques is driving the growth of the market
  • Investment in research and development activities along with government funding in   regenerative medicine will propel the market growth
  • Increasing number of clinical trials based on cell-based therapy is also fueling the market to grow in the forecast period
  • Development in cell banking infrastructure is boosting the market growth

Market Restraints

  • Unclear regulatory guidelines for product development is hampering the growth of the market
  • Less  availability of skilled professional may also hinder the market in the forecast period
  • Ethical concern in animal trial can hamper the market growth

Segmentation: Global Progenitor Cell-Based Market

By Type

  • Allogeneic Stem Cell

    • Musculoskeletal Disorders
    • Wounds and Injuries
    • Surgeries
    • Acute Graft-Versus-Host Disease (AGVHD)
    • Others

  • Autologous

    • Wounds and Injuries
    • Cardiovascular Diseases
    • Gastrointestinal Diseases
    • Others

By Therapeutic Application

  • Musculoskeletal Disorders
  • Wound and Injuries
  • Neurology
  • Cardiovascular Diseases (CVD)
  • Gastrointestinal Diseases
  • Surgeries
  • Others

By Cell Source

  • Adipose Tissue-Derived Mesenchymal Stem Cells
  • Bone Marrow-Derived Mesenchymal Stem Cells
  • By Embryo/Cord Blood Stem Cells
  • Others

By End User

  • Laboratory
  • Hospitals
  • Research Institute

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Rest of South America

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Australia
    • Singapore
    • Thailand
    • Philippines
    • Rest of Asia-Pacific

  • Middle East and Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In April 2019, Boehringer Ingelheim International GmbH, announced the launch of Arti Cell, a first ever registered stem cell-based veterinary medicine. This is ground breaking approved therapy which will use to reduce mild to moderate recurrent lameness related with non-septic joint inflammation in horses. With this launch, the company will enhance its product portfolio in the market
  • In January 2019, Japan government organization approved stem-cell treatment for spinal-cord injuries. This stem cell treatment is used to contract muscles and sense touch of the body. This approval will provide direction to the new era of healthcare and will create unprecedented revolution of science and medicine

Competitive Analysis:

Global progenitor cell-based market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of progenitor cell-based market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Some of the major companies functioning in global progenitor cell-based market are F. Hoffmann-La Roche Ltd, Pfizer Inc., Merck & Co., Inc., Abbott, Vericel, Novartis AG, Alcon, GlaxoSmithKline plc, BAXTER INTERNATIONAL INC, Boehringer Ingelheim International GmbH, Amgen Inc., Bristol-Myers Squibb Company, Nuvasive, Inc., Organogenesis, Inc., Nu-Tech International,  MiMedx, Stability Biologic., Takara Bio Inc., Caladrius, Biosciences, Inc., U.S. Stem Cell, Inc., Cesca Therapeutics and Osiris Therapeutics, Inc among others

Research Methodology: Global Progenitor Cell-Based Market

Data assemblage and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Reasons to Purchase this Report

  • Current and future of global progenitor cell-based market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19